HDV pre-S1 nAb

N/A

Report date: 2026/04/04 20:00:24

Base Information

Drug NameHDV pre-S1 nAb
Drug Alias NameGS-4321
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLarge envelope protein Pre-S1 inhibitors
TargetsLarge envelope protein Pre-S1
Therapy Area/IndicationsHepatitis D
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanRomania +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesN/A
Active IndicationsHepatitis D
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A